Back to Top
Go Back
Journal Photo for The Lancet Psychiatry
Peer reviewed only Open Access

The Lancet Psychiatry (LP)

Publisher : The Lancet Group
Medicine Psychiatry Mental Health
Claim Your Journal Get PRC Visit Website
e-ISSN 2215-0374
p-ISSN 2215-0366
Issue Frequency Monthly
Impact Factor 64.3
Est. Year 2014
Mobile 01425462736
DOI YES
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email lancet-ads@elsevier.com

Journal Descriptions

The Lancet Psychiatry is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes clinical research, expert reviews, and provocative comment and opinion in mental health, providing a clear, independent perspective about the clinical advances and practice-changing research shaping clinical psychiatry. The Lancet Psychiatry publishes papers that reflect the rich variety of ongoing clinical research, including psychopharmacology, psychotherapy and psychosocial approaches to all psychiatric disorders, across the life course. The journal covers innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of thinking about mental illness promoted by social psychiatry. The journal also advocates strongly for the rights of people with mental health disorders and highlights the voices of service users.

The Lancet Psychiatry (LP) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Psychiatry, Mental Health, Neuroscience, Biological Psychiatry, Clinical Psychology, Public Health, Health Policy , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2215-0366, E-ISSN: 2215-0374, Established: 2014, Impact Factor: 64.3
  • Provides Crossref DOI

  • Indexed in: Scopus, WoS, PubMed

  • Not indexed in DOAJ, UGC CARE

Indexing

Publications of LP

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Peter B Jones May, 2019
Background Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cann...
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placeb...
John Suckling November, 2018
Background The antibiotic minocycline has neuroprotective and anti-inflammatory properties that could prevent or reverse progressive neuropathic changes implicated in recent-onset schizophr...
Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up o...
Peter B Jones May, 2018
Background The long-term consequences of discontinuing antipsychotic medication after successful treatment of first-episode psychosis are not well studied. We assess the relation between ea...
Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (S...
Peter B Jones January, 2018
Background Provision of early intervention services has increased the rate of social recovery in patients with first-episode psychosis; however, many individuals have continuing severe and ...
Serum neuronal cell-surface antibodies in first-episode psychosis–Authors' reply
Peter B Jones March, 2017
We thank Feras Mustafa, and Frank Leypoldt and colleagues for their comments on our study about the prevalence and clinical characteristics of serum neuronal cell surface antibodies in first...
Reduction in adolescent depression after contact with mental health services: a longitudinal cohort study in the UK
Peter B Jones February, 2017
Background Evidence regarding the association between service contact and subsequent mental health in adolescents is scarce, and previous findings are mixed. We aimed to longitudinally asse...
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study
Peter B Jones January, 2017
Background Psychosis is a common presenting feature in antibody-mediated encephalitis, for which prompt recognition and treatment usually leads to remission. We aimed to investigate whether...
A decade into Facebook: where is psychiatry in the digital age?
Peter B Jones November, 2016
Social networking sites are a part of everyday life for over a billion people worldwide.1 They show no sign of declining popularity, with social media use increasing at three times the rate ...
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
Edward T. Bullmore June, 2020
The coronavirus disease 2019 (COVID-19) pandemic is having a profound effect on all aspects of society, including mental health and physical health. We explore the psychological, social, and...